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Summary 
Phagocytosis of Mycobacterium  tuberculosis by human mononuclear phagocytes is mediated pri- 
marily by complement receptors (CRs) but the transmembrane signaling mechanisms that reg- 
ulate phagocytosis of the bacterium are unknown. We have analyzed the activation of phos- 
pholipase D  (PLD) during phagocytosis of the virulent Erdman and attenuated H37Ra strains 
of M.  tuberculosis by human monocyte-derived macrophages (MDMs), radiolabeled with [3H]- 
lyso-phosphatidylcholine. Phagocytosis of either Erdman or H37Ra M.  tuberculosis in the pres- 
ence of autologous non-immune serum was associated with a 2.5-3-fold increase in phospha- 
tidic acid (PA).  Definitive evidence for activation of PLD by M.  tuberculosis was provided by 
markedly increased generation of the PLD-specific product phosphatidylethanol (PEt)(9.9-fold 
increases in [3HI-PEt for both Erdman and H37Ra strains compared to control, P <0.001, n = 
12), in the presence of 0.5% ethanol. Phagocytosis of opsonized zymosan (OZ), which is also 
mediated by CRs, was similarly associated with activation of PLD (12.2-fold increase in PEt, 
P  <0.001,  n  =  12).  The competitive PLD inhibitor 2,3-diphosphoglycerate (2,3-DPG) pro- 
duced concentration-dependent inhibition of PLD activity stimulated by either M.  tuberculosis 
(-78 -+ 8%) or OZ (-73 +  6%). Inhibition of PLD by 2,3-DPG was associated with concen- 
tration-dependent reductions in phagocytosis of M.  tuberculosis (-74  --+ 4%) and OZ (-68  --+ 
5%). Addition of purified PLD from Streptomyces  chromofuscus to 2,3-DPG-treated macrophages 
restored phagocytosis of M.  tuberculosis to control levels.  Inhibition of M.  tuberculosis-  or OZ- 
stimulated PA generation by ethanol was  associated with concentration-dependent reductions 
in phagocytosis of both particles. 
Incubation of MDMs with either Erdman or H37Ra M. tuberculosis, or OZ, resulted in rapid 
(onset 1 min) and sustained (60 rain) increases in the tyrosine phosphorylation (Tyr-P) of mul- 
tiple MDM  proteins. Prominent Tyr-P was noted in proteins of 150, 95, 72, 56, and 42 kD. 
The protein tyrosine kinase (PTK) inhibitors genistein and herbimycin A reduced M. tuberculo- 
sis-stimulated  PLD activity by 66-84%. Inhibition of PLD activity by genistein or herbimycin 
A was associated with inhibition ofphagocytosis of M.  tuberculosis and OZ. These data demon- 
strate  that  PLD  is  activated during macrophage phagocytosis of M.  tuberculosis  or OZ,  that 
PTKs are involved in this stimulation of PLD, and that the extent ofphagocytosis of these par- 
ticles is tightly coupled to activation of PLD. 
T 
uberculosis  is  an  infectious  disease  of global  impor- 
tance,  whose  morbidity and  mortality have  recently 
increased (1). The worsening health burden of tuberculosis 
is due, in part, to increased antibiotic resistance in the causative 
organism, Mycobacterium  tuberculosis, as well as to coinfection 
of patients with HIV (1,  2).  M.  tuberculosis is a facultative 
intracellular pathogen of human mononuclear phagocytes. 
After phagocytosis by monocytes and macrophages, M.  tu- 
berculosis survives and replicates within these cells,  despite 
the presence of multiple host antimicrobial effector mecha- 
nisms  (2). These observations suggest that a central feature 
of the pathogenesis of tuberculosis involves mycobacterial 
interference with, or evasion of, pathways of mononuclear 
phagocyte activation which normally lead to the killing of 
ingested organisms.  The signal transduction mechanisms ac- 
tivated during phagocytosis of M.  tuberculosis are unknown, 
both in regard to those transmembrane signaling pathways 
required for progression of the phagocytic process itself, as 
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macrophage microbicidal functions. 
Complement  receptors  (CR) 1 Cla,1  and  CR.3  mediate 
phagocytosis of M. tuberculosis by human monocytes, whereas 
CR.4 and the mannose receptor are additionally involved in 
uptake by macrophages (3-5). Most analyses of signal trans- 
duction during complement receptor (CR)-mediated phago- 
cytosis have  used  nonmicrobial ligands  (e.g.,  latex  beads, 
erythrocytes, or zymosan coated with C3b/C3bi)(6-9),  and 
the validity of extrapolations to the uptake of bacteria is not 
known.  Detailed analysis of phagocyte transmembrane sig- 
naling mechanisms activated by specific organisms, such as 
M.  tuberculosis,  is indicated, as the nonmicrobial models of 
CR-dependent phagocytosis differ from each other in sev- 
eral important respects,  most  notably, in the  involvement 
of additional receptor classes, the dependence of ingestion 
on  the  "activation state"  of the phagocyte, and the initia- 
tion ofantimicrobial responses (6-11). Nevertheless, previ- 
ous  work  suggests that  diglycerides and  protein kinase  C 
(PKC) regulate the CP,-dependent phagocytosis of specific 
particles (7-9,  12-14).  Andersson and  coworkers have  re- 
cently  demonstrated  that  phospholipase  D  (PLD)  is  acti- 
vated during phagocytosis of opsonized zymosan (OZ)  by 
neutrophils, and that the PLD/phosphatidic acid phospho- 
hydrolase pathway  is the  major source  of diglycerides for 
activation of PKC during this event (8). The PLD-initiated 
pathway is also the primary route of diglyceride generation 
in phagocytes stimulated by soluble agonists such as formy- 
lated peptides and complement component C5a (15,  16). 
The  aims  of  the  present  study  were  to  determine 
whether PLD is activated during phagocytosis of M.  tuber- 
culosis  or OZ  by human  macrophages,  and  to  analyze the 
relation between activation of PLD and the extent of parti- 
cle phagocytosis. 
Materials and Methods 
Chemicals.  Hepes,  zymosan,  2,3-diphosphoglycerate  (2,3- 
DPG), trypan blue, leupeptin, PMSF, aprotinin, bovine pancre- 
atic trypsin, phosphatidylethanol (PEt), and phosphatidic acid (PA) 
were obtained from Sigma Chemical Co. (St. Louis, MO). P,  PMI 
1640  and  PBS  were  from  GIBCO  BKL  (Gaithersburg,  MD), 
Middlebrook 7H9  broth was from BBL Microbiology Systems 
(Cockeysville, MD), and 7H11 agar, oleic acid-albumin-dextrose- 
catalase enrichment medium, and auramine-rhodamine stain were 
from Difco Laboratories (Detroit, Ml). Teflon wells were obtained 
from SaviUex Corp. (Minnetonka, MN). All organic solvents (HPLC 
grade)  were obtained from Fisher  (Fairlawn,  NJ).  [3H]-l-O-alkyl- 
lyso-PC,  [3H]-dipalmitoylphosphatidylcholine (DPPC)  and  the 
reagents for Western blot detection by ECL were  from Amer- 
sham  Corp.  (Arlington Heights,  IL).  HSA and  genistein were 
*Abbreviations used in  this paper: 2,3-DPG,  2,3-diphosphoglycerate; CP,, 
complement  receptor;  DPPC,  dipalmitoylphosphatidylcholine; MDM, 
monocyte-derived  macrophage; MOI,  multiplicity of infection;  MP,, 
mannose receptor; OZ, opsonized zymosan; PA, phosphatidic acid; PEt, 
phosphatidylethanol; PKC,  protein  kinase C;  PLD, phospholipase D; 
PPD, purified protein derivative; PTK,  protein tyrosine kinase; Tyr-P, 
tyrosine phosphorylation. 
purchased from Calbiochem Novabiochem (San Diego, CA). S. 
chromofuscus PLD  and  herbimycin A  were  from  Biomol  (Ply- 
mouth Meeting, PA). PY-20 ot-P-Tyr mAb was from ICN Im- 
munoBiologicals (Costa Mesa, CA). 
Preparation of Macrophage Monolayers.  Peripheral blood mono- 
nuclear cells were isolated from healthy, purified protein deriva- 
tive (PPD)-negative, adult volunteers, cultured in Teflon wells, 
and  monocyte-derived macrophages  (MDM)  were  purified  as 
previously described (4). Monolayers were washed and incubated 
in P,.PMI-Hepes with 2.5% serum for use in experiments. MDM 
viability was assessed by exclusion of trypan blue, and monolayer 
density by nuclei counting with napthol blue-black (17). 
Bacteria.  The virulent Erdman (35801;  American Type Cul- 
ture Collection [ATCC], Rockville, MD) and attenuated H37P, a 
(ATCC 25177)  strains  of M.  tuberculosis were cultured and pre- 
pared for use in experiments as previously described (3, 4).  The 
final preparation of M.  tuberculosis contained >90% single bacte- 
ria,  with  >~75% viability by  determination  of colony  forming 
units (CFU). For experiments in which killed M. tuberculosis were 
used, bacteria were heated to 80~  for 1 h, and the efficiency of 
heat killing was verified by absence of growth on 7H11  agar. 
Analysis of PLD Activity.  MDMs were cultured in 6-well tis- 
sue culture plates at ,'-'2.0 ￿  106 MDMs/well, and radioisotopi- 
cally labeled with  [3H]-l-O-alkylqyso-PC (5  uCi/well) for 90 
min at 37~  in R.PMI-20 mM Hepes with 2.5% serum. After re- 
peated washings, MDMs were incubated with M.  tuberculosis or 
semm-OZ at a multiplicity of infection (MOI) of 10:/. In certain 
assays, 0.5% ethanol was added 5 min before M. tuberculosis or OZ 
to permit detection of the specific transphosphatidylation prod- 
uct, [3H]-PEt, as a metabolically stable index of PLD activity (15, 
16).  After a 30-rain incubation, reactions were terminated with 
1.7 volumes of ice-cold methanol, MDMs were scraped, placed 
in polypropylene tubes, and 3.3 volumes of CHCI3 added. No vi- 
able mycobacteria were present after CHC13/MeOH  extraction, 
as determined by culture on 7Hll  agar.  After phase separation, 
the CHC13 layer was dried, and [3H]-PA and pH]-PEt were iso- 
lated by TLC  in an ethyl acetate/iso-octane/acetic  acid (9:5:2) 
solvent  system  (23),  by  co-migration  with  pure  phospholipid 
standards.  Quantitation of [3H]-cpm in  PA and PEt  were  per- 
formed  by  liquid  scintillation  spectrophotometry,  and  counts 
were  normalized for total CPM  in phospholipid to  correct for 
minor differences in labeling between experiments. Neither 2,3- 
DPG, ethanol, genistein, nor herbimycin A affected the viability 
of MDM or M. tuberculosis. Only herbimycin A caused a decrease 
in monolayer density, which was dose-dependent (maximal re- 
duction of 18  +  5% at 0.6 ~g/ml). For the PLD assay, [3H]-PEt 
cpm were normalized to total [3H]-cpm in phospholipid to cor- 
rect for the herbimycin A-induced reduction in monolayer density. 
Exogenous  Substrate Assay qfi PLD Activity.  PLD activity of in- 
tact M.  tuberculosis was analyzed using an exogenous substratc as- 
say developed by Brown et al. (I 8), with the following modifica- 
tions. [3H]-DPPC was used as the PLD substrate and presented as 
mixed vesicles  containing phosphatidylethanolamine/phosphati- 
dylinositol-4,5-bisphosphate/DPPC at  molar ratios of 16:1.4:1, 
with  0.4  uCi  [3H]-DPPC/sample.  Lipids  were  dissolved  in 
CHCl3/MeOH (2:1), dried under N 2 and resuspended in 51) mM 
Hepes (pH 7.5), 3 mM EGTA, 8 n~Vl KCl, 1 mM DTT, by son- 
ication for 11) rain at 25~  10 ILl of the lipid substrate was incu- 
bated with M. tuberculosis, buffer, or purified PLD from S. chromo- 
fi,scus in RPMI, 20 mM Hepes, 2.5% serum, for 30 rain at 37~ 
in a reaction volume of 100  btl. R.eactions were terminated with 
five volumes of CHC13/MeOH  12:1), and samples analyzed for 
[3HI-PA. 
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Method* 
Phase-contrast  Trypsin  Trypan 
microscopy  proteolysis  blue 
Control  808 -4- 33  792  +  41  822 _+ 46 
2,3-DPG (10 mM)  388  _+  17  409  +  22  393  -4- 9 
Ethanol (0.75%)  313  +- 16  289  +  20  297  _+  17 
Genistein (300 ixM)  145 +  9  155 +  11  140 +  6 
Herbimycin A (0.6 b~g/ml)  259 +  14  244 +  13  266  +_ 8 
*Mean + SEM of triplicate determinations  from two experiments;  50-2(X) 
MDMs were analyzed  for each condition. 
Analysis of Phagocytosis.  Phagocytosis  of M.  tuberculosis was 
determined as previously described  (3, 4). Briefly, MDMs adher- 
ent to  glass coverslips  (~2  X  105 MDMs/coverslip) in 24-well 
plates were incubated with M. tuberculosis (MOI 10:1) in RPMI- 
20 mM Hepes with 2.5% autologous non-immune serum. After 
incubation for 30-120 rain, MDMs were washed repeatedly  to 
remove nonadherent bacteria,  fixed in 10% formalin and stained 
with auramine-rhodamine. Previous electron microscopic studies 
of this assay have indicated that all adherent (total cell-associated) 
mycobacteria are phagocytosed,  both under control conditions, as 
well as in experiments in which phagocytosis  is inhibited or aug- 
mented (3, 4, 19). Adherent bacteria were quantitated by fluores- 
cence microscopy of triplicate  coverslips  for  each  experimental 
condition (50-200 MDMs/coverslip), and results of a set of ex- 
periments expressed  as the mean (_+  SEM)  number of adherent 
M. tuberculosis/MDM. 
Phagocytosis  of OZ  was  analyzed  by phase-contrast micros- 
copy,  as noted previously (20, 21).  Zymosan particles were op- 
sonized with 25% fresh human serum for 30 rain at 37~  washed 
and presented to MDMs at a particle to MDM ratio of 10:1. After 
a  30-rain incubation, monolayers were  washed  repeatedly  and 
fixed in 2.5% glutaraldehyde,  before microscopy.  In select exper- 
iments, the accuracy of phase-contrast determinations of zymosan 
phagocytosis were confirmed by two additional methods; (a) lim- 
ited tryptic digestion and (b) staining with trypan blue. (a) 30 min 
after the addition ofOZ, MDM monolayers were washed and in- 
cubated with 2.5% trypsin for  10 min at 37~  before fixation. 
Since controlled exposure  to trypsin results in proteolysis of CR3 
and mannose receptors  (MRs),  attached  zymosan particles are re- 
moved whereas ingested particles are unaffected,  and can be enu- 
merated by phase-contrast  microscopy (21, 22). (b) MDM mono- 
layers  were  prepared  and  incubated with  OZ  for  30  rain,  as 
described above. 0.01% trypan blue was added, and coverslips an- 
alyzed  by  phase-contrast  microscopy.  Attached  particles  are 
stained  with the dye,  whereas  phagocytosed  zymosan retains  its 
clear appearance  (23). Triplicate coverslips were analyzed for each 
condition. Results of the  analysis of OZ phagocytosis  by these 
three methods were in close agreement (Table l). 
Analysis of Protein Tyrosine Phosphorylation.  MDMs  were  ad- 
hered to 12-well tissue culture plates (,~1.0  X 106 cells/well)  and 
cultured in RPMI (pH 7.4),  20 mM Hepes,  2.5% serum. M.  tu- 
berculosis was added to MDM monolayers at a MOI of 10:1, and 
incubated for various times, at 37~  in 5% CO2. At the end of the 
incubation, monolayers  were washed  with ice-cold PBS,  1 mM 
vanadate  and then lysed in 100 I,l of 1% Triton X-100, 20 mM 
Tris (pH  8.0),  140 mM NaCl,  I  mM Na3VO 4,  2 mM EDTA, 
10% glycerol,  1 mM PMSF, 20 txM leupeptin, 0.15 bL/ml aproti- 
nin. After incubation on ice for 20 min, lysates were centrifuged 
at 14,000 g for 15 rain at 4~  and supernatants  transfered to sep- 
arate  tubes.  Supernatants contained no viable mycobacteria,  as 
determined by plating on 7H11  agar. Supernatants were boiled in 
an equal volume of electrophoresis  sample  buffer,  subjected to 
SDS-PAGE electrophoresis,  transferred to PVDF membrane, and 
Western blotted with PY-20 cx-P-Tyr mAb, with detection by 
enhanced chemiluminescence (ECL)(24,  25). To correct for the 
effects of herbimycin A on density of the MDM monolayer, pro- 
tein concentrations of Triton X-100 extracts were determined by 
the bicinchoninic  acid method (33), and equal amounts of protein 
were used for the analysis of tyrosine phosphorylation (Tyr-P). 
Analysis of Data.  Data  from  each  experimental group  were 
subjected to an analysis of normality and variance. Differences be- 
tween  experimental groups  composed  of normally distributed 
data were analyzed for statistical significance using Student's t test. 
Non-parametric evaluation of other data sets was performed with 
the Mann-Whitney Rank Sum test.  Analysis of correlation was 
performed with the Spearman Rank Order test (27). 
Results 
Phagocytosis of M.  tuberculosis or  Opsonized  Zymosan  by 
Human Macrophages Is Accompanied by Activation of Phospholi- 
pase D.  The  PLD  activity  of human  macrophages  was 
quantitated by accumulation of the PLD-specific transphos- 
phatidylation product,  PEt,  in the presence of 0.5%  etha- 
nol.  MDMs  were  radiolabeled with  [3H]-l-O-alkyl-lyso- 
PC, and [3HI-PEt generation was determined by thin layer 
chromatography.  As  shown  in  Fig.  1  A,  resting macro- 
phages exhibited very little PLD activity, as PEt accumula- 
tion in the 30 rain buffer control was not significantly dif- 
ferent than the basal value at time =  0. In contrast, MDMs 
incubated with either the  virulent Erdman or the  attenu- 
ated H37Ra strains of M.  tuberculosis showed significant in- 
creases in PLD  activity (9.9-fold over control for each,  P 
<0.001,  n  =  12).  The two  strains of M.  tuberculosis were 
phagocytosed to a similar extent by MDMs; at a multiplic- 
ity of infection (MOl) of 10:1, the mean (-+ SEM) number 
of ingested bacilli per macrophage was 5.36 +-- 0.58 for Erd- 
man and 5.84  +  0.51  for H37Ra  (n  =  3).  Incubation of 
macrophages with OZ also resulted in increased PLD activ- 
ity (12.2-fold over control, P  <0.001, n  =  12). 8.08  +  0.63 
zymosan particles were ingested/MDM, and the number of 
attached OZ per MDM was  1.61  +  0.23  (Table 2). Treat- 
merit of MDMs with  100 nM PMA served as the positive 
control, with generation of 647  +  96 cpm [3H]-PEt (P < 
0.001, n =  10). 
Phagocytosis of M.  tuberculosis or OZ in the  absence of 
ethanol was  accompanied by increased production of PA, 
the  physiologic product  of PLD  catalysis  (Fig.  1  B).  The 
mean (--_ SEM)  [3H]-PA cpm in resting MDMs was 177  + 
24, whereas it was 498  +  76 or 461  +  59 cpm after addi- 
tion of H37Ra or Erdman M.  tuberculosis, respectively, and 
688  +  65  cpm in macrophages  phagocytosing OZ  (P  < 
0.001 for each, n =  5). Incubation with increasing concen- 
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Attachment of Opsonized Zymosan  by Human Macropha~es 
Opsonized zymosan 
Phagocytic*  Attachment  Total cell- 
index  index  association 
Control  808  +  33  161  +  14  969  +  48 
2,3-DPG(10mM)  388_+  17  187_+  11  575_+  32 
Ethanol (0.75%)  313  +  16  191  _+  ll)  514  +  21 
Genistein (300 I.tM)  145  _+ 9  212  _+  13  357  +  10 
Herbimycin A  (0.6  btg/ml)  259  _+  14  205  -4-  10  464  _+ 21 
Serom-OZ particles were incubated with M1)M monolayers  at a parti- 
cle/MDM  ratio  of 10:1. At  30  min,  ingested  and  attached  zymosan 
were  enumerated  by  phase-contrast  microscopy.  In  selected  experi- 
ments,  samples were subjected  to limited tryptic  digestion  or staining 
with trypan blue to verify the accuracy of phase-contrast  determinations 
ofzymosan phagocytosis  (Table  1). 
*Phagocytic  index:  number of particles  ingested  by  t00  MDMs.  At- 
tachment  index:  number  of particles  attached  (extracellularty)  to  100 
MDMs.  Total cell-association:  the sum  of the phagocytic and  attach- 
ment indices. 
Figure 1.  Activation  ofmacrophage phospholipase 1) accompanies the 
phagocytosis of M.  tuberculosis  or opsonized  zymosan.  (A) MDM mono- 
layers radiolabeled  with  [3H]-l-O-alkyl-lyso-PC were incubated  under 
the indicated conditions.  At 30 rain, lipids were extracted and PLD activ- 
ity assayed as [3H]-PEt accmnulation.  Basal value represents PEt at time = 
0, while control  is PEt at 30 rain in  the presence  of media alone.  [3HI- 
cpm in  PEt  were normalized  for total  cpm in  phospholipid  (PL). Data 
represent mean  +  SEM of duplicate samples from 12 determinations.  (/3) 
Experiments were conducted  as in A, except for the absence of ethanol. 
Results are from five experinaents. 
trations  of ethanol  (0-0.75%  vol/vol) resulted in  decreased 
accumulation  of PA and  increased production  of PEt  (data 
not shown).  This inverse relationship  of PA and PEt gener- 
ation to ethanol concentration is characteristic of the unique 
transphosphatidylation  capacity  of PLD  enzymes  (16).  As 
with  M.  tuberculosis,  PA and  PEt generation  during phago- 
cytosis of OZ  were inversely related, dependent  on ethanol 
concentration  (data  not  shown).  Fig.  2  shows  the  kinetics 
of MDM  PEt accumulation in response to M.  tuberculosis or 
OZ.  An increase in PLD activity was noted  1 rain after the 
addition  of either particle,  and  PEt  levels reached  a  maxi- 
mum  between  30-60  rain.  PA generation  was  also  detect- 
able within  1 rain  of the addition  of M.  tuberculosis  or OZ, 
and  peaked  at  30-60  rain  (data  not shown).  The  maximal 
rates of PEt and PA generation occurred within the first  15 
min after particle addition  (Fig. 2). 
Activation  of PLD  during  macrophage  phagocytosis  of 
M.  tuberculosis  did  not  require  viability  of the  organisms, 
since  heat-killed  M.  tuberculosis  also  stimulated  significant 
PLD  activity  (live: 252  -+  13  [3H]-PEt  cpm;  dead:  202  -+ 
24 cpm,  n  =  3).  Additional evidence that  the PLD activity 
accompanying  phagocytosis  of M.  tuberculosis  was  not  of 
mycobacterial  origin was  obtained  with an  exogenous sub- 
strate  assay which  has  been  used to measure  PLD  activities 
from a wide variety of sources,  including mammalian  cells, 
E  Q. 
O 
T 
UJ 
a. 
350 
300 
250 
200 
150 
100 
50 
10  20  30  40  50  60 
Time  (rain) 
Figure  2.  Time-dependence  of PLI)  activation  during  macrophage 
phagocytosis  of M.  tuberculosis or  OZ.  MDMs  were  incubated  with 
H37Ra  M.  tuberculosis (solid squares) or OZ  (solid circles) at  a particle  to 
MDM ratio of 10:1. At the indicated times, [3H]-PEt was measured as an 
index of PLD activity. Open squares represent  PEt accunmlation  in con- 
trol MDMs, in the absence of M. tuberculosis  or OZ. Results are mean  + 
SD of duplicate  determinations  from  a single experiment,  representative 
of five. Four experiments with Erdman M. tuberculosis  yielded very similar 
results. 
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PLD from S.  chromofuscus  was added to vesicles  composed 
of [3H]-DPPC, phosphatidylethanolamine,  and phosphati- 
dylinositol-4,5-bisphosphate,  and [3H]-PA was determined 
as a measure of PLD activity. Incubation of live M.  tubercu- 
losis with  the  vesicle substrate  for 30  rain  at 37~  did not 
result in increased production of PA when compared with 
buffer-treated  samples  (603  +  36  [3H]-PA cpm for M.  tu- 
berculosis vs, 598 +  22 cpm for buffer control, n =  3). In con- 
trast, addition of S.  chromofuscus PLD to [3H]-DPPC-labeled 
vesicles  resulted  in  marked  PA  accumulation  (32,858  ___ 
1692 cpm). 
Previous  work has  demonstrated  that  in  the  absence  of 
serum,  or in  the  presence  of heat-inactivated  serum  (HI- 
serum, 56~  30 rain), phagocytosis of M.  tuberculosis by hu- 
man macrophages and monocytes is reduced approximately 
70-80%,  which  correlates  with  the  absence  of C3  on the 
bacterial surface  (3,  4).  To further examine the  association 
between  stimulation  of  macrophage  PLD  activity  and 
phagocytosis  of  M.  tuberculosis, we  studied  the  serum- 
dependence  of  phagocytosis-associated  PLD  activation. 
The level of PLD activity stimulated by M.  tuberculosis was 
reduced 70  +- 8% in the absence of serum and 61  +  7% in 
the presence of HI-serum (n  =  3).  Correspondingly, phago- 
cytosis of M.  tuberculosis was reduced  76  +-  7%  in  the  ab- 
sence of serum and 69  +  6% in the presence of HI-serum 
(n  =  3).  Thus, both M.  tuberculosis-stimulated  PLD activity 
and the degree of mycobacterial phagocytosis exhibit simi- 
lar serum-dependence. 
The  Competitive  PLD  Inhibitor  2,3-Diphosphoglycerate  In- 
hibits  M.  tuberculosis-stimulated  PLD Activity and Phagocytosis 
of the Bacterium.  To  further  evaluate  the  role  of PLD  in 
phagocytosis of M.  tuberculosis, we studied the effects of the 
competitive  PLD  inhibitor  2,3-diphosphoglycerate  (2,3- 
DPG)  on  PEt  accumulation  and  mycobacterial  ingestion 
(28).  2,3-DPG  (2-10 raM)  inhibited  M.  tuberculosis-stimu- 
lated  PLD  activity  in  a  concentration-dependent  manner, 
with a maximal reduction of 78  +-- 9% (Fig. 3). These levels 
of 2,3-DPG  did  not  affect  the  viability  or  density  of the 
macrophage  monolayer,  or  the  viability  of M.  tuberculosis 
(data  not shown).  MDMs  incubated  with  2,3-DPG  (2-10 
raM)  also exhibited  decreased phagocytosis of M.  tuberculo- 
sis  (Fig.  3),  with a maximal inhibition  of 74  -Z-_ 5%.  Treat- 
ment  with  2,3-DPG  resulted  in  decreases  in  both  the 
phagocytic index (Fig. 3, Table 1), and the number ofmac- 
rophages phagocytosing at least  one  tubercle  bacillus  (data 
not shown). The results in Fig. 3 represent the inhibition of 
phagocytosis at 30 rain after the addition of M.  tuberculosis. 
Similar  inhibition  of the  uptake  of M.  tuberculosis by 2,3- 
DPG was noted at both earlier (15 rain) and later (120 min) 
time  points  (data  not shown).  The  effects of 2,3-DPG  on 
macrophage  PLD  activity and phagocytosis were  not lim- 
ited  to  the  ingestion  of M.  tuberculosis,  since  5  mM  2,3- 
DPG  produced  a  54  -+  6%  reduction  in  OZ-stimulated 
PLD  activity  (n  =  6),  and  a  52  +  5%  inhibition  of the 
phagocytosis of OZ  (Table  2).  Treatment  with  2,3-DPG 
resulted in a small increase in the attachment index of OZ; 
from 161  +  14 OZ/100 MDMs to 187  +  11. 
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Figure  3.  The  PLD  inhibitor 2,3-diphosphoglycerate reduces mac- 
rophage PLD activity and phagocytosis of M.  tuberculosis. Macrophages 
were incubated with the indicated concentrations of 2,3-DPG or buffer 
control for 15 rain at 37~  H37Ra M. tuberculosis  was added to MDMs 
and accumulation of PEt (filled bars) and phagocytosis (striped bars) were 
determined at 30 min. Results (mean + SEM, n = 4) are expressed as the 
percentage of PLD activity and phagocytosis  of control samples. Control 
macrophages phagocytosed  5.26 -+ 0.37 mycobacteria  per cell. 
Purified  Bacterial PLD Restores  PEt Accumulation  and Phago- 
cytosis  of  M.  tuberculosis  in  2,3-DPG-treated  Macrophages. 
The effects of 2,3-DPG suggest an association between the 
level of macrophage PLD activity stimulated by M.  tubercu- 
losis, and the degree of phagocytosis of the bacterium.  2,3- 
DPG is a selective inhibitor of PLD since it does not block 
several  other  activation-dependent  signal  transduction 
mechanisms in phagocytes (28),  and inhibits  purified  PLD 
in  a  competitive  manner.  However,  as  with  most  inhibi- 
tors,  conclusions  derived  from  the  use  of 2,3-DPG  are 
complicated by the potential  for nonspecific effects which 
could decrease phagocytosis by a mechanism other than in- 
hibition of PA production. To address these limitations, we 
studied the effects of purified bacterial PLD from S.  chromo- 
fi,scus on PEt accumulation and phagocytosis of M.  tubercu- 
losis. We reasoned that if activation of macrophage PLD by 
M.  tuberculosis is  tightly  coupled to phagocytosis, then  ex- 
ogenously added PLD might restore phagocytic capacity to 
MDMs  in which  endogenous PLD had been inhibited  by 
2,3-DPG. This approach of adding purified phospholipases, 
including PLD,  of bacterial  or plant  origin to  mammalian 
cells  has  been  used  successfully  to  analyze  the  effects  of 
their eukaryotic homologues on cellular activation (29, 30). 
Initial  experiments,  in the absence of M,  tuberculosis,  dem- 
onstrated  that the addition of S.  chromofuscus  PLD to  [3H]- 
lyso-PC-labeled  macrophages  resulted  in  concentration- 
dependent  accumulation  of [3H]-PEt  (results  not  shown). 
Bacterial  PLD  (2-50  tx/ml)  did not affect MDM  viability 
or the  density  of the  cell monolayer.  PEt levels  were  ele- 
vated within  1 rain of addition of S.  chromofuscus PLD, and 
continued to rise over the 30 rain assay (results not shown). 
Fig. 4 A  shows the effect of bacterial PLD on PEt accu- 
mulation by 2,3-DPG-treated macrophages incubated with 
M.  tuberculosis.  5  mM  2,3-DPG  inhibited  M.  tuberculosis- 
stimulated PLD activity by approximately 50%, which is in Table 3.  Effect  of Ethanol on Phosphatidic Acid Generation and 
Phagocytosis of M. tuberculosis 
Ethanol 
Phosphatidic  acid 
production  Phagocytosis 
[3H]-PA cpm  % change  Phagocytic  index  % change 
% vol/vol 
0  554 +  77  --  504 -+ 4l  -- 
0.10  471  +  24  -15-+ 5  449  +  32  -11  •  4 
0.25  377--+22  -32-+ 6  323  +  19  --36-+ 7 
0.50  305  +  12  -45 +  11  207+  13  -59+  10 
0.75  116 -+  17  -79 --+ I1  176 -+- 15  -65 --+ 7 
Macrophages were incubated with buffer or the indicated concentra- 
tions of ethanol for 5 rain at 37~  prior to the addition of H37Ra ,14. 
tuberculosis. PA generation and phagocytosis were determined at 30 nfin, 
and expressed as the percentage change from control values. Results are 
from three experiments performed in triplicate. 
Figure 4.  Effect  of 2,3-DPG and bacterial PLD on PEt generation and 
macrophage phagocytosis of M.  tuberculosis. (B)  MDMs, labeled with 
[3H]-lyso-PC, were incubated  with 5 mM 2,3-DPG or buffer control for 
15 rain at 37~  H37Ra M.  tuberculosis was added to all samples except 
control MDMs. S. dm~mq~scus PLD (50 l~/ml)  was added to the indicated 
samples concurrent with M. tuberculosis. (B) MDMs were incubated with 
5 mM 2,3-DPG or buffer control for 15 min before exposure to M. tuber- 
culosis. Bacterial PLD was added to the indicated  samples concurrent with 
mycobacteria and phagocytosis was assayed at 3(I rain. Results are from 
three experiments  performed in triplicate. 
close agreement with the results presented in Fig. 3. Addi- 
tion of bacterial PLD (50 ~z/ml) restored PEt accumulation 
in  these  2,3-DPG-treated  macrophages  to  approximately 
the level found in untreated MDMs after incubation with 
M.  tuberculosis. In separate experiments, S.  chromofuscus PLD 
did not affect the viability of M. tuberculosis (data not shown). 
The effects of 2,3-DPG and bacterial PLD on phagocytosis 
of M.  tuberculosis are demonstrated in Fig. 4  B.  Incubation 
of macrophage monolayers with 5  mM 2,3-DPG resulted 
in an ~'-'50% decrease in mycobacterial ingestion, compara- 
ble to that shown in Fig. 3.  S.  chromofuscus PLD produced a 
concentration-dependent increase in the level of phagocy- 
tosis  of M.  tuberculosis  by  2,3-DPG-treated macrophages. 
Incubation ofmacrophages with 50 ~/ml bacterial PLD re- 
sulted in essentially complete recovery of control levels of 
mycobacterial phagocytosis. 
Inhibition  of M.  tuberculosis-  or  OZ-stimulated  PA  Genera- 
tion  by  Ethanol  Is  Accompanied  by  Inhibition  of Phagocytosis. 
Incubation of cells with low concentrations of ethanol has 
been  used  to  study  the  involvement of PLD  in  various 
physiologic processes (16, 31). By serving as a nucleophilic 
substrate  for  the  transphosphatidylation reaction,  ethanol 
diverts PA generation to the production of PEt, thereby ef- 
fectively inhibiting the  generation of the  product  of the 
PLD-catalyzed  reaction without  inhibiting enzyme turn- 
over.  Incubation of macrophages with ethanol (0.1--0.75% 
vol/vol) for  5  rain before addition of M.  tuberculosis pro- 
duced a concentration-dependent  inhibition of PA genera- 
tion,  with  a  maximal reduction of 79  +  11%  (Table  3). 
Ethanol also inhibited macrophage phagocytosis of M.  tu- 
berculosis  in  a  concentration-dependent manner,  with  a 
maximal reduction of 65  +  7%  (Table 3).  These concen- 
trations of ethanol did not affect macrophage viability, den- 
sity of the MDM monolayer, or the viability ofM.  tubercubsis 
(data  not  shown).  Similarly, ethanol-treatment of macro- 
phages resulted in dose-dependent inhibition of OZ-stimu- 
lated PA generation, with a maximal reduction of 71  +  8% 
at 0.75%  ethanol. The degree  of phagocytosis of OZ was 
reduced in a parallel manner by exposure to ethanol, with a 
maximal inhibition of 60 +  6% (n =  4). As with 2,3-DPG, 
incubation of MDMs  with ethanol resulted in a  small in- 
crease in the attachment index for OZ; from  167  +  10 to 
191  +  9 (Table 2). 
Macrophage  Phagocytosis  of M.  tuberculosis Is Accompanied by 
h~crea~-ed Protein Tyrosine Phosphorylation.  To study the mech- 
anism ofphagocytosis-associated activation of PLD, we an- 
alyzed levels of protein Tyr-P in resting MDMs and those 
undergoing phagocytosis ofM.  tubewulosis.  Protein tyrosine 
kinases (PTKs) activate PLD in many cell types, including 
phagocytic leukocytes  (24,  25,  32,  33).  Recent  evidence 
indicates that  PTKs  function in  transmembrane signaling 
after the ligation of [32 integrins (34, 35) and Fcy receptors 
590  Phospholipase D and Phagocytosis ofM. tubercuk~sis Figure 5.  M. tuberculosis  induces an increase in macrophage protein ty- 
rosine phosphorylation. MDM monolayers were incubated at 37~  with 
buffer or H37Ra M. tuberculosis  for the indicated times. 1% Triton X-100 
lysates were subjected to SDS-PAGE, Western blotted with PY-20 mAb 
to P-Tyr, followed by HRP-conjugated  (x-mouse IgG, with detection by 
ECL. Results are representative of data from five identical experiments. 
(Fc'yRs)(37, 38). MDMs were incubated with M.  tuberculo- 
sis  or  buffer  control,  under  conditions  identical  to  those 
used in assays of PLD activity and phagocytosis, and Tyr-P 
proteins were analyzed in Triton X-100  extracts by West- 
em blotting with (i-P-Tyr mAb. Resting MDMs contained 
several Tyr-P proteins (Fig. 5).  Incubation of MDMs with 
M.  tuberculosis was  associated with  a  significant increase in 
protein Tyr-P, particularly in proteins of""150,  95, 72,  56, 
and 42 kD. Increased levels of protein Tyr-P were detected 
within 1 min of the addition of M.  tuberculosis, and persisted 
for 60 rain. M.  tuberculosis alone contained no detectable ty- 
rosine  phosphoproteins  (data  not  shown).  Incubation  of 
MDMs  with  OZ  also  resulted  in  rapid  and  sustained  in- 
creases in protein Tyr-P (not shown). 
Tyrosine Kinase Inhibitors  Reduce the Accumulation  qf Tyr-P 
Proteins Induced  by M.  tuberculosis.  To  study  the  relation 
between M.  tuberculosis-induced  increases in Tyr-P and  (a) 
stimulation of PLD and (b) phagocytosis, we studied the ef- 
fect  of two  highly  specific  PTK  inhibitor,  genistein  and 
herbimycin A,  on  these  responses  (39,  40).  Incubation  of 
MDMs  with  either  genistein  or  herbimycin  A  produced 
concentration-dependent inhibition of M.  tuberculosis-induced 
protein  Tyr-P  (Fig.  6).  The  PTK  inhibitors  also  reduced 
basal levels of Tyr-P proteins in resting MDMs,  suggesting 
that a balance of tyrosine kinase and phosphatase activities 
exists in unstimulated macrophages. 
Tyrosine Kinase Inhibitors  Block  the Activation of PLD Dur- 
ing Phagocytosis qf M.  tuberculosis or OZ and Reduce the Extent 
of Particle Ingestion.  Incubation  of MDMs  with  genistein 
resulted in concentration-dependent inhibition of M.  tuber- 
culosis-stimulated  PLD  activity, with a maximal decrease of 
66  •  15%  (Fig.  7  A).  Genistein  also  produced  a  dose- 
dependent inhibition of OZ-stimulated PLD  activity, with 
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Figure 6.  Genistein and herbimycin A inhibit M.  tuberculosis-induced 
protein  tyrosine phosphorylation. (A) MDMs were incubated with  the 
indicated concentrations of genistein or 0.l% DMSO solvent control for 
15 rain at 37~  H37Ra  M.  tuberculosis  or buffer was added for an addi- 
tional 15 rain, and P-tyr proteins analyzed as described in the legend to 
Fig. 5.  (B)  Macrophages incubated with  0.1% DMSO or the indicated 
concentrations ofherbimycin A for 18 h, were incubated with M. tubercu- 
losis or buffer for 15 rain.  Protein Tyr-P was analyzed as noted  above. 
Results represent data from one of five experiments for each inhibitor. 
a maximal 74  +  9% reduction  (n  =  3).  Inhibition of PLD 
activity by  genistein  was  accompanied  by  concentration- 
dependent  reductions  in  phagocytosis  of  M.  tuberculosis 
(-62  +  8%,  Fig.  7  A)  and  OZ  (-82  +  7%,  Table  2). 
Treatment  of MDMs  with  0.1-43.6  btg/ml  herbimycin A 
resulted in concentration-dependent inhibition of M.  tuber- 
culosis-stimulated  PLD  activity, with  a  maximal reduction 
of 87  +  5%  (Fig. 7  B).  0.6  Ixg/ml herbimycin A  reduced 
PEt  accumulation  secondary to  OZ  by 73  +  9%.  Herbi- 
mycin  A  also produced  dose-dependent  inhibition  of the 
phagocytosis of M.  tuberculosis and  OZ,  with  maximal re- 
ductions of 78  --- 9% (Fig. 7  B)  and 68  +  7% (Table 2), re- 
spectively. These data indicate that macrophage phagocyto- Figure  7.  Tyrosine  kinase inhibitors reduce M.  tubercttb~sis-stimulated 
PL1) activity and mycobacterial  phagocytosis. (A) MI)Ms were incubated 
with genistein, or solvent control, as in Fig. 6 A. H37Ra M. tuberculosis 
was added and PLD activity (filk'd bars) and phagocytosis (striped bars) 
were determined at 30 rain and expressed as the percentage of control 
values. (/3) MDMs were pretreated with herbimycin A or solvent control 
as in Pig. 6 B. PL1) activity and phagocytosis were determined as in A. 
Control macrophages phagocytosed 5.14 +  0.28 mycobacteria per cell. 
Results are mean •  SEM of four determil~ations for each assay. 
sis of two complement-opsonized particles is accompanied 
by prominent increases in protein Tyr-P, and that PTK in- 
hibitors block the ingestion of M.  tuberculosis and OZ. 
The  Level  qf  M.  tuberculosis-stimulated  PLD  Activity  Is 
Highly  Correlated  with  the Extent of Mycobacterial  Phagocytosis 
by Human  Macrophages.  An attempt was made to quantify 
the relation between the degree of PLD activity stimulated 
by M.  tuberculosis and the extent ofphagocytosis of the bac- 
terium.  The results of all experiments in which PLD activ- 
ity was modified (negatively by the exclusion of serum, use 
of HI-serum,  treatment  with  2,3-DPG,  ethanol,  genistein 
or  herbinwcin  A,  and  positively,  by  addition  of bacterial 
PLD)  were  expressed  as  a  percentage  of control  values 
(PLD  activity  and  phagocytosis)  for  a  given  experiment. 
The  correlation  coefficient  for  the  association  between 
PLD activity and phagocytosis of M.  tuberculosis was 0.949, 
which was highly significant (P <0.005, n  =  15). 
Discussion 
The present studies indicate that phagocytosis of virulent 
or  attenuated  strains  of M.  tuberculosis  by  human  macro- 
phages  is  accompanied  by  activation  of PLD.  This  is  the 
first documentation  that PLD is activated during phagocy- 
tosis  of a  microorganism,  as well  as  the  first report  of this 
signal transduction pathway accompanying ingestion of any 
particle by mononuclear phagocytes. That this PLD activity 
is  of macrophage  rather  than  mycobacterial  origin  is  sup- 
ported  by  several  lines  of  evidence.  First,  macrophage 
membrane lipids were  radiolabeled  in phosphatidylcholine 
substrate  (with  [3H]-lyso-PC) before the addition of M.  tu- 
berculosis. Second, phagocytosis of heat-killed M.  tuberculosis 
was associated with a level of PLD activity that was compa- 
rable to that elicited by live bacteria.  Third, live M.  tubercu- 
losis alone  exhibited  no detectable  PLD  activity against  an 
exogenous PC substrate.  Fourth,  macrophage phagocytosis 
of OZ was also accompanied by an increase in PLD activity. 
The level ofmacrophage PLD activity correlated closely 
with  the  extent  of phagocytosis  of MI  tuberculosis  or  OZ 
under a variety of experimental  conditions.  However,  our 
limited  understanding  of the  cellular  localization  of PLD 
and the likelihood that several isoforms of this enzyme exist 
in  mammalian  cells  (16),  preclude  more  detailed  conclu- 
sions  from  the  inhibitor  studies.  For  example,  although 
2,3-DPG  is  known to be  a  competitive  inhibitor  of puri- 
fied bacterial PLD (28), the mechanism by which it inhibits 
manmlalian  PLD is unknown.  The high  charge-density of 
2,3-DPG makes passive diffusion through the lipid bilayer 
unlikely.  However,  metabolism  of 2,3-DPG  (e.g.,  acyla- 
tion-deacylation)  may  significantly  affect  its  partitioning 
between  extracellular  and intracellular  compartments.  It is 
of interest that the concentration-dependence  of 2,3-DPG- 
mediated inhibition  of PLD is very similar in macrophages 
and neutrophils  (28). 
The strong correlation between  the level of macrophage 
PLD  activity and  the  degree  of phagocytosis suggests,  but 
does  not prove,  a  causal  linkage  between  these  processes. 
This  hypothesis is  strengthened  by the  restoration  of con- 
trol  levels  of  phagocytosis  in  2,3-DPG-treated  macro- 
phages  by  addition  of bacterial  PLD  (at  a  concentration 
which resulted in restoration of control levels of PEt accu- 
mulation). Although the mechanism by which exogenously 
added phospholipases mimic their endogenous homologues 
is  incompletely  understood,  this  method  has  been  applied 
sucessfully to PLD, PLC, PLA2, and sphingomyelinase (29, 
30).  It  is  clear  that  exogenous  phospholipases  can  use 
plasma membrane lipids as substrates to catalyze the forma- 
tion  of bioactive  lipid  products.  However,  questions  re- 
main regarding lipase access to specific leaflets of the mem- 
brane,  and  the  localization  of  products  to  membrane 
microdomains containing distal  effector molecules.  In fact, 
these issues of interracial  catalysis and intramembrane local- 
ization remain largely unsolved for endogenous phospholi- 
pases as well (16). 
Our  results  and  the  work  of Andersson  and  coworkers 
(8,  12)  indicate  that  the  association  of PLD  activity  and 
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phagocytic cell type. Concerning the initiation of these re- 
sponses,  the  primary  phagocyte  surface  receptors  which 
mediate the phagocytosis of M.  tuberculosis (3-5), and OZ 
(23,  41) are CRs. Macrophage MRs also contribute to the 
phagocytosis of virulent M. tuberculosis (4) and OZ (20, 42). 
Because of their prominent role in the ingestion of these 
particles, CRs are also likely to function in the accompany- 
ing activation of PLD. Such a role for CRs is supported by 
the serum-dependence of PLD stimulation in macrophages 
and  the  activation  of PLD  after cross-linking  of CRs  in 
neutrophils (16). 
Since there  are  significant differences in  certain  of the 
biochemical requirements and functional consequences of 
phagocytosis ofEC3b/bi, OZ, and M.  tuberculosis, compar- 
ative studies of signal  transduction during uptake of these 
particles will be informative (6, 7). It is likely that these dif- 
ferences involve the activation, and perhaps deactivation, of 
distinct  host  biochemical  signaling  pathways  by  each  of 
these particles. Since virulent and attenuated strains  of M. 
tuberculosis stimulated similar levels of macrophage PLD ac- 
tivity (in the 60 min after addition to MDMs), we hypoth- 
esize that this early activation of PLD is a relatively proxi- 
mal  step  in  the  interaction  between  M.  tuberculosis  and 
macrophages, and that it is more likely to be involved in 
the regulation of mycobacterial phagocytosis than to func- 
tion as a biochemical determinant of virulence. 
Phagocytosis  requires  attachment  of  the  extracellular 
particle to plasma  membrane receptors on the phagocytic 
cell,  followed by ingestion of the particle within a mem- 
brane-bound phagosome. The data in Table 1 indicate that 
inhibition of OZ-stimulated PLD activity and phagocytosis 
was not accompanied by inhibition of the adherence of OZ 
to the macrophage surface.  In fact, inhibition of PLD by 
different mechanisms was associated with a small increase in 
the attachment index for OZ. These considerations support 
the  following  model  of signal  transduction  during  CR- 
mediated phagocytosis:  (a)  ligation of complement recep- 
tors by the phagocytic particle results in,  (b)  activation of 
PLD, which is involved in the regulation of (c) particle in- 
gestion.  The effects of ethanol, which diverts the  genera- 
tion of the  physiologic product, PA,  to  the metabolically 
inactive PEt, support this hypothesis, since the catalytic ac- 
tivity of PLD is preserved, yet phagocytosis is markedly in- 
hibited.  Thus,  we  propose that  PLD  inhibitors dissociate 
the attachment of a particle from its phagocytosis. In sup- 
port of this model, incubation of electroporated polymor- 
phonuclear leukocyte/neutrophil (PMN)(which  were not 
competent for phagocytosis) with OZ resulted in stimula- 
tion of PLD in the absence of particle ingestion (8). 
The effects of genistein and herbimycin A  suggest that 
PTKs function in both stimulation of PLD and the regula- 
tion  of CR-mediated  phagocytosis.  Consistent  with  this 
hypothesis, M.  tuberculosis and OZ stimulate significant in- 
creases in macrophage protein Tyr-P. Although it is recog- 
nized that the use ofPTK inhibitors may reduce the degree 
of phagocytosis  by mechanisms  other  than  inhibition  of 
PLD activity, this hypothesis is  consistent with the estab- 
lished roles of PTKs in: (a) [32 integrin-dependent signaling 
(34,  35),  (b) the activation of PLD in many cell types, in- 
cluding  phagocytic  leukocytes  (24,  25,  32,  33),  and  (c) 
phagocytosis  mediated  by  FcyRs  (37,  38).  In  addition, 
Mege and coworkers have demonstrated that phagocytosis 
of unopsonized  zymosan is  associated  with  activation  of 
PTKs,  although  the specific receptors responsible for this 
response are unknown (36). 
The mechanism by which stimulation of PLD is coupled 
to  the  progression of phagocytosis is  unknown.  PA acti- 
vates several lipid-modifying enzymes, such  as  PI-PLCy  1, 
phospholipase  AI,  and  phosphoinositide-4-  and  5-kinases 
(44),  which may participate in the membrane remodeling 
and/or biochemical signaling which occur during phagocy- 
tosis.  PA also  activates protein kinases that likely function 
as  effectors in  PLD-initiated signaling  pathways  (45).  Fi- 
nally, the conversion of PA to DG, and the resultant acti- 
vation of PKC, could promote CR-mediated phagocytosis 
by multiple mechanisms, including phosphorylation of OR1, 
MARCKS,  and other, as yet undefined, substrates  (8,  13, 
14, 32). In addition to its proposed role in the regulation of 
receptor-mediated  phagocytosis,  the  activation  of  PLD 
which accompanies particle uptake may modify subsequent 
phagocyte functions, including antimicrobial responses, via 
generation of PA and DG (31,  45,  46).  Molecular defini- 
tion of the relevant signaling components (PLD isoforms, 
PTKs), their intracellular loci, and detailed quantitation of 
their respective  activities  will  be  required  to  further our 
understanding  of the  role  of PLD  in  receptor-mediated 
phagocytosis. 
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